These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9885460)

  • 41. [The International Network of Agencies for Health Technology Assessment (INAHTA) or the need for collaboration in evaluating health technologies].
    Asua Batarrita J
    Med Clin (Barc); 1999; 112 Suppl 1():86-9. PubMed ID: 10618805
    [TBL] [Abstract][Full Text] [Related]  

  • 42. International experience and health sector reform: the challenge for developing health systems.
    Collins C; Green A; Hunter D
    World Hosp Health Serv; 1994; 30(2):20-5. PubMed ID: 10142969
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Emerging health technologies: informing and supporting health policy early.
    Wild C; Langer T
    Health Policy; 2008 Aug; 87(2):160-71. PubMed ID: 18295925
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Best practice in undertaking and reporting health technology assessments. Working group 4 report.
    Velasco M; Perleth M; Drummond M; Gürtner F; Jørgensen T; Jovell A; Malone J; Rüther A; Wild C
    Int J Technol Assess Health Care; 2002; 18(2):361-422. PubMed ID: 12053427
    [No Abstract]   [Full Text] [Related]  

  • 45. Transfer of technology assessment to health policy makers.
    Blanpain JE
    Int J Technol Assess Health Care; 1986; 2(1):117-25. PubMed ID: 10276245
    [No Abstract]   [Full Text] [Related]  

  • 46. Technology assessment and transfer in district health systems.
    Tjam FS
    World Hosp Health Serv; 1994; 30(2):3-8. PubMed ID: 10142971
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Making processes reliable: a validated pubmed search strategy for identifying new or emerging technologies.
    Varela-Lema L; Punal-Riobóo J; Acción BC; Ruano-Ravina A; García ML
    Int J Technol Assess Health Care; 2012 Oct; 28(4):452-9. PubMed ID: 22995101
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Three worlds of health technology assessment: explaining patterns of diffusion of HTA agencies in Europe.
    Löblová O
    Health Econ Policy Law; 2016 Jul; 11(3):253-73. PubMed ID: 26670267
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differences in evaluating health technology assessment knowledge translation by researchers and policy makers in China.
    Liu W; Shi L; Pong RW; Dong H; Mao Y; Tang M; Chen Y
    Int J Technol Assess Health Care; 2014 Dec; 30(6):612-20. PubMed ID: 25816828
    [TBL] [Abstract][Full Text] [Related]  

  • 50. European Collaboration in Health Technology Assessment (HTA): goals, methods and outcomes with specific focus on medical devices.
    Erdös J; Ettinger S; Mayer-Ferbas J; de Villiers C; Wild C
    Wien Med Wochenschr; 2019 Sep; 169(11-12):284-292. PubMed ID: 30725440
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Joint project of the international network of agencies for health technology assessment--Part 1: Survey results on diffusion, assessment, and clinical use of positron emission tomography.
    Hastings J; Adams EJ
    Int J Technol Assess Health Care; 2006; 22(2):143-8. PubMed ID: 16571188
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Health care technology in Australia and New Zealand: contrasts and cooperation.
    Hailey DM; Roseman C
    Health Policy; 1990 May; 14(3):177-89. PubMed ID: 10113350
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Moving low value care lists into action: prioritizing candidate health technologies for reassessment using administrative data.
    Soril LJJ; Seixas BV; Mitton C; Bryan S; Clement FM
    BMC Health Serv Res; 2018 Aug; 18(1):640. PubMed ID: 30111308
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The time for cost-effectiveness in the new European Union member states: the development and role of health economics and technology assessment in the mirror of the Hungarian experience.
    Gulácsi L
    Eur J Health Econ; 2007 Jun; 8(2):83-8. PubMed ID: 17436027
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Priority setting for health technology assessment. Theoretical considerations and practical approaches. Priority setting Subgroup of the EUR-ASSESS Project.
    Henshall C; Oortwijn W; Stevens A; Granados A; Banta D
    Int J Technol Assess Health Care; 1997; 13(2):144-85. PubMed ID: 9194351
    [No Abstract]   [Full Text] [Related]  

  • 56. Africa's search for communication technologies for education: a reflection on problems and prospects.
    Ofori-ansa K
    Dev Commun Rep; 1983 Sep; (43):3-5, 13. PubMed ID: 12339166
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Technology assessment.
    SCI Nurs; 2002; 19(4):187-9. PubMed ID: 12616783
    [No Abstract]   [Full Text] [Related]  

  • 58. Women, health, and medical technology.
    Stauning I
    Int J Technol Assess Health Care; 1994; 10(2):273-81. PubMed ID: 8034406
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [HTA goes Europe: European collaboration on joint assessment and methodological issues becomes reality].
    Nachtnebel A; Mayer J; Erdös J; Lampe K; Kleijnen S; Schnell-Inderst P; Wild C
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):291-9. PubMed ID: 26354129
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The uses of modern technologies: problems and perspectives for industrialized and developing countries.
    Banta D
    Bull Pan Am Health Organ; 1984; 18(2):139-50. PubMed ID: 6487871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.